Azegami T - Search Results

1

Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease.

Nakayama T, Yamaguchi S, Hayashi K, Uchiyama K, Tajima T, Azegami T, Morimoto K, Yoshida T, Yoshino J, Monkawa T, Kanda T, Itoh H. Nakayama T, et al. Among authors: azegami t. Front Med (Lausanne). 2023 Mar 6;10:1137981. doi: 10.3389/fmed.2023.1137981. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36950508 Free PMC article.

2

Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.

Kashima K, Yuki Y, Mejima M, Kurokawa S, Suzuki Y, Minakawa S, Takeyama N, Fukuyama Y, Azegami T, Tanimoto T, Kuroda M, Tamura M, Gomi Y, Kiyono H. Kashima K, et al. Among authors: azegami t. Plant Cell Rep. 2016 Mar;35(3):667-79. doi: 10.1007/s00299-015-1911-9. Epub 2015 Dec 11. Plant Cell Rep. 2016. PMID: 26661780

3

The mucosal immune system: From dentistry to vaccine development.

Kiyono H, Azegami T. Kiyono H, et al. Among authors: azegami t. Proc Jpn Acad Ser B Phys Biol Sci. 2015;91(8):423-39. doi: 10.2183/pjab.91.423. Proc Jpn Acad Ser B Phys Biol Sci. 2015. PMID: 26460320 Free PMC article. Review.

4

Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2.

Hayashi K, Sasamura H, Ishiguro K, Sakamaki Y, Azegami T, Itoh H. Hayashi K, et al. Among authors: azegami t. Kidney Int. 2010 Jul;78(1):69-78. doi: 10.1038/ki.2010.81. Epub 2010 Apr 7. Kidney Int. 2010. PMID: 20375993 Free article.

5

[Angiotensin receptor vaccines].

Sasamura H, Azegami T, Itoh H. Sasamura H, et al. Among authors: azegami t. Nihon Rinsho. 2011 Sep;69(9):1633-8. Nihon Rinsho. 2011. PMID: 21922766 Review. Japanese.

6

Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy.

Azegami T, Sasamura H, Hayashi K, Itoh H. Azegami T, et al. Hypertens Res. 2012 May;35(5):492-9. doi: 10.1038/hr.2011.212. Epub 2011 Dec 8. Hypertens Res. 2012. PMID: 22158111

7

Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartan.

Hayashi K, Sasamura H, Azegami T, Itoh H. Hayashi K, et al. Among authors: azegami t. J Atheroscler Thromb. 2012;19(8):736-46. Epub 2012 Apr 28. J Atheroscler Thromb. 2012. PMID: 22576470 Free article.

8

[Current status of vaccination therapy for hypertension].

Sasamura H, Azegami T, Itoh H. Sasamura H, et al. Among authors: azegami t. Nihon Rinsho. 2012 Sep;70(9):1627-32. Nihon Rinsho. 2012. PMID: 23012814 Review. Japanese.

9

Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension.

Oguchi H, Sasamura H, Shinoda K, Morita S, Kono H, Nakagawa K, Ishiguro K, Hayashi K, Nakamura M, Azegami T, Oya M, Itoh H. Oguchi H, et al. Among authors: azegami t. Hypertension. 2014 Oct;64(4):784-91. doi: 10.1161/HYPERTENSIONAHA.113.02973. Epub 2014 Jun 30. Hypertension. 2014. PMID: 24980670

10

Novel transgenic rice-based vaccines.

Azegami T, Itoh H, Kiyono H, Yuki Y. Azegami T, et al. Arch Immunol Ther Exp (Warsz). 2015 Apr;63(2):87-99. doi: 10.1007/s00005-014-0303-0. Epub 2014 Jul 16. Arch Immunol Ther Exp (Warsz). 2015. PMID: 25027548 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters